HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: 2-Week Home Monitoring, 6-Week Home Monitoring.
- Who it may be relevant to
- Registry conditions: Postpartum, Hypertension, Hypertensive Disorder of Pregnancy. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Postpartum remote blood pressure monitoring programs for patients with hypertensive disorders of pregnancy (HDP) are becoming part of standard postpartum management. Existing programs range in duration from 2 to 6 weeks but there has not been any evaluation as to what program duration is optimal. The primary objective of this study is to evaluate the impact of program duration on clinical outcomes for patients participating in a single institution's postpartum remote blood pressure monitoring program for patients with HDP.
Interventions
- Diagnostic test 2-Week Home Monitoring
Those who are randomized into the 2-week intervention arm will be unenrolled from the postpartum remote blood pressure monitoring program and therefore will no longer be transmitting twice daily blood pressures for review. - Diagnostic test 6-Week Home Monitoring
HOPE-BP provides remote monitoring for the 35% of approximately 2,800 annual births at our institution complicated by HDP. Eligible patients enroll at hospital discharge into a 6-week program, submitting blood pressure readings twice daily via Epic's MyChart Care Companion. Participants receive immediate automated feedback, and a dedicated Maternal Fetal Medicine nursing team reviews data daily (Monday-Friday, 8 AM-4 PM), initiating or adjusting antihypertensive therapy as needed.
Primary outcome measures
- Diastolic Blood Pressure [Time frame: Week 6]
Secondary outcome measures (6)
- Systolic Blood Pressure at 6 weeks post-partum [Time frame: Week 6]
- 6-Week Post-partum Follow-up Rates [Time frame: Week 6]
- Unscheduled OB visit, triage visit, ED visit, or readmission rates [Time frame: Week 6]
- Patient Satisfaction Survey responses at 6 weeks [Time frame: Week 6]
- Rate of severe hypertension [Time frame: Week 6]
- Rate of new hypertension diagnosis at 6 weeks postpartum [Time frame: Week 6]
Eligibility criteria
Inclusion criteria
- 18 years or older
- Discharged after delivery at University of Minnesota Medical Center
- Enrolled into the HOPE-BP Program
Exclusion criteria
- Ongoing antihypertensive medication use at 2 weeks (time of randomization)
- Have a medical comorbidity that would not be clinically appropriate to randomize
- Patients opted out of clinical research
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Diagnostic
Study locations
United States · 1 center
- University of Minnesota — Minneapolis
Identifiers
NCT: NCT07204756 · OBGYN-2025-34107